Hurst v. Enphase Energy, Inc.

Background

Gregory A. Hurst brought a putative securities class action against Enphase Energy, Inc., Chief Executive Officer Badrinarayanan Kothandaraman, and Chief Financial Officer Eric Branderiz. The first amended complaint alleged that, between February 26, 2019, and June 16, 2020, defendants made materially false or misleading statements, or failed to disclose adverse information, about Enphase’s financial performance. Hurst alleged that Enphase’s United States and international revenue was inflated and that its reported gross-margin expansion was overstated.

The complaint relied substantially on a June 17, 2020, report by Prescience Point Capital Management. The report alleged that Enphase’s financial statements were fictional, that at least $205.3 million of reported 2019 United States revenue was fabricated, and that much of the company’s gross-margin expansion was not genuine. Hurst alleged that Enphase’s stock price fell from $52.76 per share on June 16, 2020, to $39.04 per share on June 17, 2020, after the report was published.

Legal standard and judicial notice

The defendants moved to dismiss under Federal Rule of Civil Procedure 12(b)(6), which tests whether a complaint legally states a claim for relief. Securities-fraud claims also must satisfy heightened pleading requirements under Federal Rule of Civil Procedure 9(b) and the Private Securities Litigation Reform Act. Those rules require a plaintiff to identify each allegedly misleading statement, explain why it was misleading, and plead particularized facts supporting a strong inference that defendants acted with the required fraudulent intent, known as scienter.

The court granted defendants’ request for judicial notice. It treated some exhibits as incorporated into the complaint, treated certain Securities and Exchange Commission filings as public records, and took notice of the existence of the remaining publicly available documents because their accuracy was not disputed.

Section 10(b) and Rule 10b-5 claim

Hurst’s first claim arose under Section 10(b) of the Securities Exchange Act and Securities and Exchange Commission Rule 10b-5. The court explained that such a claim requires a material misrepresentation or omission, scienter, a connection with the purchase or sale of a security, reliance, economic loss, and loss causation.

The court rejected defendants’ argument that Hurst failed to plead loss causation. Loss causation asks whether the alleged misstatement, rather than some other event, foreseeably caused the plaintiff’s loss. The court held that Hurst adequately pleaded this element by alleging that the Prescience Report disclosed the alleged problems and was followed by a substantial decline in Enphase’s stock price. The court also rejected defendants’ argument that a short-seller report could never qualify as a corrective disclosure.

The court nevertheless granted the motion to dismiss because the first amended complaint did not adequately plead a material misrepresentation or omission. The court found that the complaint largely presented financial data in a way favorable to Hurst’s theory without enough supporting facts. It noted that the complaint identified no restatement of Enphase’s accounting and no missed earnings that revealed the effect of the alleged fraud.

The court also found that the complaint did not identify an accounting standard that Enphase had misapplied. Although the complaint alleged that Enphase adopted the ASC 606 revenue-recognition standard and improperly deferred revenue, it did not explain why the company’s treatment violated generally accepted accounting principles. The court stated that Hurst needed to plead facts showing that Enphase’s accounting decision was not simply one of multiple permissible judgments. The other asserted grounds for falsity likewise lacked the particularity required by the Private Securities Litigation Reform Act.

Scienter

The court stated that the failure to plead falsity was dispositive but also addressed scienter to assist with amendment. It found that the allegations concerning the magnitude of Enphase’s alleged accounting violations and other warning signs lacked sufficient detail. The allegations based on statements from former employees did not establish the employees’ reliability or personal knowledge, did not provide corroboration, and did not satisfy the court that Hurst and his counsel had independently investigated the allegations.

The court also rejected the insider-trading allegations as a basis for scienter. Seven of the eight identified insiders were not defendants, making their sales irrelevant to the scienter of the named defendants. The remaining allegation concerned Branderiz’s sale of 100,249 shares for $5.4 million on June 3, 2020. The court found that the complaint did not explain why the sale was unusual or suspicious, including by alleging the proportion of Branderiz’s holdings sold or his past trading patterns. The court also found it implausible that Branderiz had advance warning of the Prescience Report.

Section 20(a) claim and disposition

Section 20(a) imposes control-person liability for a primary violation of Section 10(b) or Rule 10b-5. Because Hurst failed to plead a Section 10(b) or Rule 10b-5 violation, the court granted the motion to dismiss the Section 20(a) claim against Kothandaraman and Branderiz.

The court granted defendants’ Motion to Dismiss with leave to amend. Hurst was required to file an amended complaint, if he could correct the identified defects, no later than 60 days from the date of the order. The court stated that no parties or claims could be added without leave of court.